LED light therapy has been a staple of high-end dermatology practices and medical spas for years. The challenge has always been access. Professional-grade devices cost thousands of dollars, and treatments at specialist clinics run well above what most people will pay for routine skincare. LightStim and Hand & Stone Massage and Facial Spa just changed that equation. On April 3, 2026, the two companies announced the national rollout of LightStim’s FDA-cleared Elipsa device across Hand & Stone’s 600-plus US and Canadian locations. A technology that was previously available only in medical and premium aesthetic settings is now accessible at a neighborhood spa in most major American cities.
The expansion follows a successful pilot program that demonstrated strong guest adoption and measurable treatment outcomes for franchise owners.
What Elipsa does and why FDA clearance matters
Elipsa is cleared by the FDA to treat fine lines and wrinkles on the entire face and mild to moderate inflammatory acne. Those two clearances cover the most common skin concerns that drive the majority of facial spa visits, which explains why the pilot program showed strong adoption.
FDA clearance is worth understanding in the skincare context. The beauty and wellness industry is full of devices and products that make claims about skin improvement without any independent regulatory verification. An FDA-cleared device has demonstrated to the agency’s standards that it is safe and effective for its stated indications. For consumers navigating a market full of unverified claims, that distinction matters.
The device uses LightStim’s patented MultiWave technology, which delivers multiple wavelengths of light simultaneously rather than sequentially. Different wavelengths of light interact with skin tissue in different ways. Red light wavelengths stimulate cellular activity associated with collagen production. Near-infrared wavelengths penetrate deeper tissue. Blue light targets the bacteria that contribute to acne. Delivering these wavelengths together in optimized combinations is the technical differentiation that LightStim’s patented approach provides.
The touchless system design is also practically significant. Because Elipsa operates without direct skin contact, estheticians can be fully present with the guest during the treatment rather than managing device placement and movement. That operational benefit contributed to the strong franchise owner reception during the pilot.
Why the Hand & Stone network makes this a genuinely big deal for accessible skincare
Hand & Stone operates over 600 locations across the United States and Canada, making it one of the largest professional spa franchises in North America. Its locations are typically in accessible suburban and urban markets, priced for regular visits rather than special occasions. The franchise model means that treatments are delivered by licensed estheticians with standardized training, ensuring consistent results across locations.
Bringing professional LED therapy into that distribution network does something that neither company could achieve alone. LightStim has strong clinical credentials and device quality but limited direct consumer reach. Hand & Stone has massive consumer reach but needs science-backed treatments that differentiate its facial offerings from lower-cost competitors. The partnership solves both problems simultaneously.
According to Grand View Research’s analysis of the LED phototherapy market, the professional LED therapy market is growing at a significant compound annual growth rate driven by increasing consumer awareness of non-invasive skin treatments and growing demand for evidence-based skincare outside of traditional medical settings. The Hand & Stone national rollout positions LightStim directly within that growth trend at meaningful scale.
LightStim’s background gives the technology credibility
LightStim was founded in 2000 and designs and manufactures its devices in California. The company has sold more than one million retail devices and supports over 50,000 professional accounts worldwide, including medical practices, esthetician studios, and professional athletic training facilities. That scale of commercial deployment provides a substantial real-world evidence base for the technology’s performance beyond the clinical studies that informed FDA clearance.
The California manufacturing point is worth noting in the context of medical device quality. FDA-registered medical device manufacturing in the United States is subject to Current Good Manufacturing Practice regulations that require rigorous quality management systems, documentation, and inspection regimes. Consumers choosing between LED devices can use manufacturing location as one proxy for quality standard adherence.
The at-home extension creates a complete skincare ecosystem
The partnership also allows guests to purchase select LightStim at-home devices through Hand & Stone spas, creating a pathway from professional treatment to home maintenance. That retail integration reflects how the most successful professional skincare brands build loyalty: introduce consumers to the technology in a professional setting where results are visible, then offer a home maintenance option that extends the relationship between visits.
According to the Professional Beauty Association, the professional-to-retail conversion model consistently generates higher lifetime customer value than either channel alone in the skincare and spa market. Guests who purchase retail products through their spa provider return more frequently and spend more per visit than those who do not.
For Hand & Stone franchise owners, adding both a premium treatment service and a retail product line represents a meaningful revenue diversification beyond the core massage and facial menu.
Sources
- Grand View Research — LED Phototherapy Market
- Professional Beauty Association — Industry Research
- LightStim — Official Website
- Hand & Stone — Official Website
Editorial disclosure
This article is based on a press release issued by LightStim and has been independently rewritten and editorially expanded. It covers the national rollout of LightStim’s Elipsa device across Hand & Stone spa locations. Elipsa is FDA-cleared for the treatment of fine lines, wrinkles, and mild to moderate inflammatory acne. Individual treatment results may vary. This article does not constitute medical advice. Market context is sourced from Grand View Research and the Professional Beauty Association. Commentary reflects the author’s own assessment. The information provided on this website is for informational and educational purposes only. Our content is derived strictly from verified online sources to ensure accuracy and objectivity. This analysis does not constitute financial, investment, or professional advice. Readers are encouraged to consult with qualified professionals before making decisions based on this information. For more information, please see our full DISCLAIMER.
